Navigation Links
PharMEDium Announces Electronic 222 Ordering Initiative
Date:12/3/2007

FIRST AMONG PHARMACY COMPOUNDERS; ENABLES CONVENIENT, SECURE, VIRTUALLY

REAL-TIME ORDERING OF CLASS II CONTROLLED SUBSTANCES

LAKE FOREST, Ill., Dec. 3 /PRNewswire/ -- PharMEDium Services, LLC, the leading provider of outsourced hospital compounded sterile preparations, announced a first-in-the-industry electronic 222 controlled substance ordering system for its entire line of Schedule II Controlled Substances. The initiative will be launched in beta-site form during the month of December, said David Jonas, PharMEDium Chairman and Chief Executive Officer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051202/PHARMEDIUMLOGO)

The company's investment in e-222 is consistent with its strong commitment to patient safety, quality, and superior customer service, and aligns with moves by the U.S. Drug Enforcement Administration (DEA) and drug/pharmacy industry leaders to use e-commerce to expedite ordering and reduce errors and rework, Jonas said.

The Drug Enforcement Administration (DEA) Office of Diversion Control (ODC) requires a form 222 for all orders of Schedule II Controlled Substances. Until 2005, these orders were processed only via paper forms, which take about 20 minutes to complete. DEA processes about 5.5 million 222 forms yearly, but the drug industry, notably drug distributors, has rapidly upped electronic orders since the agency's Controlled Substances Ordering System (CSOS) was launched in August 2005. Through July 2007, DEA had processed more than three million electronic CSOS orders since the system went into place, with the typical transaction lasting less than 20 seconds, according to the ODC. DEA estimates that the average electronic 222 form costs $6 to process, as opposed to $39 for a paper form.

"The compounding industry has an important role in enhancing quality and improving the healthcare system as a whole, and this initiative will contribute strongly to that effort," said PharMEDium President Rich Kruzynski, R.Ph. "We look forward to making a significant contribution, and to leading our industry down the path of electronic 222 ordering."

About PharMEDium Services, LLC

For more than 15 years, PharMEDium has been the leading provider of outsourced compounding services. In that time, PharMEDium has grown into a nationwide network of state licensed and federally registered compounding centers providing trusted solutions to more than 1,800 hospitals throughout the United States. Managed by licensed pharmacists and staffed by certified technicians, the company complies with all applicable state laws and FDA regulations, including USP Chapter < 797 >, as well as DEA and cGMP Requirements.


'/>"/>
SOURCE PharMEDium Services, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PharMEDium Announces Availability of Pre-Filled Operating Room Perioperative Compounded Drugs
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps ... in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally ... one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... search for and donate to Give To Cure’s campaign that is crowdfunding clinical trials ... users make and share payments through a smart device. In 2015 alone, Venmo processed ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Dr. Justin ... announce their 2nd Annual No Cost Dental Day to individuals in need. The event ... purpose of this No Cost Dental Day is to provide dental care to community ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... DIEGO, Feb. 4, 2016  Aethlon Medical, Inc. ... affinity biofiltration devices to treat life-threatening diseases, today ... 2016 ended December 31, 2015. ... objectives set forth in our last quarterly call, ... reinforce our long-term objective to establish the Aethlon ...
Breaking Medicine Technology: